Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease
- PMID: 17985251
- DOI: 10.1007/s12017-007-8017-7
Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease
Abstract
Objective: To analyze genetically based impairment in histamine-metabolising enzymes in patients with Parkinson's disease (PD).
Methods: Leukocytary DNA from 214 PD patients and a control group of 295 unrelated healthy individuals was studied for nonsynonymous histamine N-methyltransferase (HNMT) and diamine oxidase (ABP1) polymorphisms by using amplification-restriction analyses.
Results: An association of the HNMT Thr105Ile polymorphism, but not of the ABP1 His645Asp polymorphism, with PD was observed. Patients with PD showed a higher frequency of homozygous HNMT genotypes leading to high activity with a gene-dose effect (P < 0.001), as compared to healthy subjects. These findings were independent of gender, but the association with the HNMT polymorphism is higher among patients with late-onset PD (P < 0.0001).
Conclusion: These results, combined with previous findings indicating alterations in histamine levels in patients with PD, suggest that alterations of histamine homeostasis in the SNC are associated with the risk for PD.
Similar articles
-
The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.Neuromolecular Med. 2008;10(4):356-61. doi: 10.1007/s12017-008-8040-3. Epub 2008 Jun 10. Neuromolecular Med. 2008. PMID: 18543121
-
Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene.World J Gastroenterol. 2006 Jan 28;12(4):615-20. doi: 10.3748/wjg.v12.i4.615. World J Gastroenterol. 2006. PMID: 16489678 Free PMC article.
-
Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis.Clin Exp Allergy. 2007 Aug;37(8):1175-82. doi: 10.1111/j.1365-2222.2007.02769.x. Clin Exp Allergy. 2007. PMID: 17651147 Clinical Trial.
-
Histamine pharmacogenomics.Pharmacogenomics. 2009 May;10(5):867-83. doi: 10.2217/pgs.09.26. Pharmacogenomics. 2009. PMID: 19450133 Review.
-
Histamine N-Methyltransferase in the Brain.Int J Mol Sci. 2019 Feb 10;20(3):737. doi: 10.3390/ijms20030737. Int J Mol Sci. 2019. PMID: 30744146 Free PMC article. Review.
Cited by
-
Histaminergic Innervation of the Ventral Anterior Thalamic Nucleus Alleviates Motor Deficits in a 6-OHDA-Induced Rat Model of Parkinson's Disease.Neurosci Bull. 2025 Apr;41(4):551-568. doi: 10.1007/s12264-024-01320-0. Epub 2024 Dec 2. Neurosci Bull. 2025. PMID: 39621239 Free PMC article.
-
An association study between Heme oxygenase-1 genetic variants and Parkinson's disease.Front Cell Neurosci. 2014 Sep 24;8:298. doi: 10.3389/fncel.2014.00298. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25309329 Free PMC article.
-
Genetic variability of histamine receptors in patients with Parkinson's disease.BMC Med Genet. 2008 Mar 17;9:15. doi: 10.1186/1471-2350-9-15. BMC Med Genet. 2008. PMID: 18366640 Free PMC article.
-
Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor.Parkinsonism Relat Disord. 2010 Feb;16(2):112-4. doi: 10.1016/j.parkreldis.2009.08.011. Epub 2009 Sep 20. Parkinsonism Relat Disord. 2010. PMID: 19773194 Free PMC article.
-
Determining the Effect of the HNMT, STK39, and NMD3 Polymorphisms on the Incidence of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations.J Mol Neurosci. 2018 Apr;64(4):574-580. doi: 10.1007/s12031-018-1048-8. Epub 2018 Mar 21. J Mol Neurosci. 2018. PMID: 29564728
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous